Tech Company Financing Transactions
StemCyte Funding Round
Sycamore Ventures participated in a $9 million Series E funding round for StemCyte. The round was announced on 9/28/2006.
Transaction Overview
Company Name
Announced On
9/28/2006
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Series E
Investors
Proceeds Purpose
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
13800 Live Oak Ave.
Baldwin Park, CA 917106
USA
Baldwin Park, CA 917106
USA
Phone
Website
Email Address
Overview
StemCyte, Inc. is a leading, global umbilical cord blood (UCB) stem cell transplantation and therapeutic products company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jonas Wang
Chief Medical Officer
Shinn-Zong Lin
Chief Medical Officer
Lawrenc Petz
Chief Operating Officer
Deepak Chhabra
Chief Operating Officer
Charles Lu
Chief Scientific Officer
Wise Young
Browse more venture capital transactions:
Prev: 9/28/2006: DoublePositive Marketing Group venture capital transaction
Next: 9/28/2006: Idev Technologies venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs